Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasimelteon in Jet Lag Disorder (JET Study)
NCT03291041Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Jul 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tasimelteon in jet lag disorder, sponsored by Vanda Pharmaceuticals Inc.. Started Jul 2016; status: completed.
02
Drugs
tasimelteon
03
Conditions
jet lag disorder
Beyond the preview
Go deeper on NCT03291041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291041.